3034 Stock Overview
Engages in management of dispensing pharmacies and business process outsourcing contracting businesses in Japan.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
No risks detected for 3034 from our risk checks.
Qol Holdings Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥1,334.00 |
| 52 Week High | JP¥1,989.00 |
| 52 Week Low | JP¥1,187.00 |
| Beta | 0 |
| 11 Month Change | -12.06% |
| 3 Month Change | -27.89% |
| 1 Year Change | -30.05% |
| 33 Year Change | -14.43% |
| 5 Year Change | -2.84% |
| Change since IPO | 280.60% |
Recent News & Updates
Shareholder Returns
| 3034 | JP Consumer Retailing | JP Market | |
|---|---|---|---|
| 7D | -10.2% | -5.5% | -10.6% |
| 1Y | -30.0% | -5.7% | 7.2% |
Return vs Industry: 3034 underperformed the JP Consumer Retailing industry which returned -5.7% over the past year.
Return vs Market: 3034 underperformed the JP Market which returned 7.2% over the past year.
Price Volatility
| 3034 volatility | |
|---|---|
| 3034 Average Weekly Movement | 7.7% |
| Consumer Retailing Industry Average Movement | 4.6% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in JP Market | 9.8% |
| 10% least volatile stocks in JP Market | 3.3% |
Stable Share Price: 3034's share price has been volatile over the past 3 months.
Volatility Over Time: 3034's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 5,856 | Takashi Nakamura | www.qolhd.co.jp |
Qol Holdings Co., Ltd., together with its subsidiaries, engages in management of dispensing pharmacies and business process outsourcing contracting businesses in Japan. The company operates dispensing pharmacies through one-on-one store opening based on one-on-one trust relationships with medical institutions. It also undertakes sales and marketing research activities for pharmaceutical companies; and provides temporary staff dispatch for pharmacists, nurses, registered sellers, registered dietitians, etc. In addition, the company offers clinical trial support services for pharmaceuticals and food products; support, monitoring, and technician dispatch services of managers for various processes, from planning of trial execution plans to monitoring, secretariat support, statistical analysis, and the presentation of conference papers; and publishes books and magazines for medical professionals and patients.
Qol Holdings Co., Ltd. Fundamentals Summary
| 3034 fundamental statistics | |
|---|---|
| Market cap | JP¥49.64b |
| Earnings (TTM) | JP¥4.71b |
| Revenue (TTM) | JP¥197.69b |
10.6x
P/E Ratio0.3x
P/S RatioIs 3034 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 3034 income statement (TTM) | |
|---|---|
| Revenue | JP¥197.69b |
| Cost of Revenue | JP¥170.96b |
| Gross Profit | JP¥26.73b |
| Other Expenses | JP¥22.01b |
| Earnings | JP¥4.71b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 126.28 |
| Gross Margin | 13.52% |
| Net Profit Margin | 2.38% |
| Debt/Equity Ratio | 58.1% |
How did 3034 perform over the long term?
See historical performance and comparisonDividends
2.5%
Current Dividend Yield24%
Payout RatioDoes 3034 pay a reliable dividends?
See 3034 dividend history and benchmarks| Qol Holdings dividend dates | |
|---|---|
| Ex Dividend Date | Sep 27 2024 |
| Dividend Pay Date | Dec 02 2024 |
| Days until Ex dividend | 50 days |
| Days until Dividend pay date | 116 days |
Does 3034 pay a reliable dividends?
See 3034 dividend history and benchmarks